Of course, it should be noted that targeting inhibition of p-EGFR/IMPDH2 signaling may be able to improve esophageal cancer treatment efficacy, and the question as to whether there is a relationship between IMPDH2 and EGFR signaling requires in-depth experimental exploration. The gene discussed is EGFR; the disease is esophageal cancer.